Quick Answer
IceCure Medical Ltd. reported Diluted EPS of $0.24 per share for fiscal year 2025.
IceCure Medical Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.24 | -20.0% |
| 2024 | $0.30 | -6.3% |
| 2023 | $0.32 | -30.4% |
| 2022 | $0.46 | +31.4% |
| 2021 | $0.35 | +59.1% |
| 2020 | $0.22 | — |
- IceCure Medical Ltd. showed a decrease of -20.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, IceCure Medical Ltd.’s diluted eps has grown by 9.1% (from $0.22 per share to $0.24 per share).
- The most recent figure is from IceCure Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: